News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,460 Results
Type
Article (40172)
Company Profile (249)
Press Release (662039)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205092)
Career Advice (2017)
Deals (35533)
Drug Delivery (98)
Drug Development (81329)
Employer Resources (172)
FDA (16290)
Job Trends (14914)
News (346955)
Policy (33123)
Tag
Academia (2578)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (49682)
ALS (91)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (124)
Approvals (16294)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11666)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (176)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2266)
Cardiovascular disease (174)
Career advice (1686)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (20)
Clinical research (66200)
Collaboration (835)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2607)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2212)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (273)
Diagnostics (6387)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (87011)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (112999)
Executive appointments (722)
FDA (17556)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (104)
Generative AI (19)
Gene therapy (304)
GLP-1 (715)
Government (4691)
Grass and pollen (5)
Guidances (67)
Healthcare (18969)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2749)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (313)
IPO (16550)
IRA (40)
Job creations (3658)
Job search strategy (1432)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7977)
Liver cancer (76)
Lung cancer (321)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13443)
Medtech (13448)
Mergers & acquisitions (19529)
Metabolic disorders (694)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1925)
NextGen: Class of 2025 (6538)
Non-profit (4526)
Now hiring (39)
Obesity (370)
Opinion (206)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (47)
People (57537)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20599)
Phase II (29136)
Phase III (21749)
Pipeline (1203)
Policy (140)
Postmarket research (2575)
Preclinical (8762)
Press Release (65)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (379)
Real estate (5938)
Recruiting (65)
Regulatory (22549)
Reports (46)
Research institute (2336)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (12)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3592)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (29)
Vaccines (694)
Venture capitalists (41)
Weight loss (241)
Women's health (35)
Worklife (16)
Date
Today (37)
Last 7 days (897)
Last 30 days (2566)
Last 365 days (32720)
2025 (10768)
2024 (35303)
2023 (40166)
2022 (51323)
2021 (55913)
2020 (54357)
2019 (46935)
2018 (35319)
2017 (32263)
2016 (31705)
2015 (37747)
2014 (31482)
2013 (26496)
2012 (28711)
2011 (29395)
2010 (27478)
Location
Africa (738)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38046)
Australia (6240)
California (6140)
Canada (2039)
China (524)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81827)
Florida (913)
Georgia (206)
Idaho (58)
Illinois (536)
India (26)
Indiana (308)
Iowa (11)
Japan (163)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4571)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (85)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1728)
New Mexico (28)
New York (1746)
North Carolina (969)
North Dakota (8)
Northern California (2684)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1381)
Puerto Rico (12)
Rhode Island (33)
South America (1107)
South Carolina (23)
South Dakota (1)
Southern California (2306)
Tennessee (102)
Texas (907)
United States (23156)
Utah (180)
Virginia (146)
Washington D.C. (62)
Washington State (553)
West Virginia (3)
Wisconsin (54)
702,460 Results for "aspen pharmacare canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
April 25, 2025
·
8 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
Press Releases
Aspen Medical Products Acquires Advanced Orthopaedics
January 30, 2025
·
2 min read
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Ferring Inc. Receives Health Canada Approval for REBYOTA® (fecal microbiota, live)
March 7, 2025
·
9 min read
Press Releases
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8, 2025
·
3 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Biotech Beach
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.
June 20, 2024
·
6 min read
Press Releases
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
April 10, 2025
·
7 min read
1 of 70,246
Next
